Home Casteddu.com	FAQ My Amedeo About	Flying Publisher
	The Medical Article of the Year 2008: Wellcome Trust Case Control Consortium. Genome-wide association study of 14,000 cases of seven common diseases and 3,000 shared controls. Nature 2007; 447:661-78. Free full-text

Breast Cancer

Free Subscription Articles published in Cancer Chemother Pharmacol Retrieve available abstracts of 29 articles: HTML format

Single Articles

July 2008
1. MA G , Tabanca N, Husnu Can Baser K, Kirimer N, et al
   Inhibition of NF-kappaB-mediated transcription and induction of apoptosis in human breast cancer cells by epoxypseudoisoeugenol-2-methyl butyrate.
   Cancer Chemother Pharmacol. 2008;.
   PubMed     Related articles    Abstract available
   
   
   June 2008
2. PARK BB , Uhm JE, Cho EY, Choi YL, et al
   Prognostic factor analysis in patients with brain metastases from breast cancer: how can we improve the treatment outcomes?
   Cancer Chemother Pharmacol. 2008;.
   PubMed     Related articles    Abstract available
   
   
   May 2008
3. LACROIX M
   MDA-MB-435 cells are from melanoma, not from breast cancer.
   Cancer Chemother Pharmacol. 2008;.
   PubMed     Related articles    Abstract available
   
   
   April 2008
4. MONTAGNA E , Cancello G, D'Agostino D, Lauria R, et al
   Central nervous system metastases in a cohort of metastatic breast cancer patients treated with trastuzumab.
   Cancer Chemother Pharmacol. 2008;.
   PubMed     Related articles    Abstract available
   
   
   March 2008
5. RUIZ M , Salvador J, Bayo J, Lomas M, et al
   Phase-II study of weekly schedule of trastuzumab, paclitaxel, and carboplatin followed by a week off every 28 days for HER2+ metastatic breast cancer.
   Cancer Chemother Pharmacol. 2008;.
   PubMed     Related articles    Abstract available
   
   
   
6. SEO JH , Kim YH, Kim JS
   Meta-analysis of pre-operative aromatase inhibitor versus tamoxifen in postmenopausal woman with hormone receptor-positive breast cancer.
   Cancer Chemother Pharmacol. 2008;.
   PubMed     Related articles    Abstract available
   
   
   
7. PIRES LA , Hegg R, Valduga CJ, Graziani SR, et al
   Use of cholesterol-rich nanoparticles that bind to lipoprotein receptors as a vehicle to paclitaxel in the treatment of breast cancer: pharmacokinetics, tumor uptake and a pilot clinical study.
   Cancer Chemother Pharmacol. 2008;.
   PubMed     Related articles    Abstract available
   
   
   
8. BULUT N , Kilickap S, Sari E, Altundag K, et al
   Response to taxanes in triple negative breast cancer.
   Cancer Chemother Pharmacol. 2008;.
   PubMed     Related articles   
   
   
   February 2008
9. BARTSCH R , Wenzel C, Gampenrieder SP, Pluschnig U, et al
   Trastuzumab and gemcitabine as salvage therapy in heavily pre-treated patients with metastatic breast cancer.
   Cancer Chemother Pharmacol. 2008;.
   PubMed     Related articles    Abstract available
   
   
   
10. CHOI BS , Robins HI
    Reversible paclitaxel-induced vocal cord paralysis with later recall with vinorelbine.
    Cancer Chemother Pharmacol. 2008;61:345-6.
    PubMed     Related articles    Abstract available
    
    
    January 2008
11. JONES RJ , Boyce T, Fennell M, Jacobs V, et al
    The impact of delay in cryo-fixation on biomarkers of Src tyrosine kinase activity in human breast and bladder cancers.
    Cancer Chemother Pharmacol. 2008;61:23-32.
    PubMed     Related articles    Abstract available
    
    
    
12. BAUR M , Drescher A, Gneist M, Dittrich C, et al
    Pharmacokinetics of oxaliplatin in patients with severe hepatic dysfunction.
    Cancer Chemother Pharmacol. 2008;61:97-104.
    PubMed     Related articles    Abstract available
    
    
    December 2007
13. TORRISI R , Balduzzi A, Ghisini R, Rocca A, et al
    Tailored preoperative treatment of locally advanced triple negative (hormone receptor negative and HER2 negative) breast cancer with epirubicin, cisplatin, and infusional fluorouracil followed by weekly paclitaxel.
    Cancer Chemother Pharmacol. 2007;.
    PubMed     Related articles    Abstract available
    
    
    
14. FABI A , Metro G, Papaldo P, Mottolese M, et al
    Impact of celecoxib on capecitabine tolerability and activity in pretreated metastatic breast cancer: results of a phase II study with biomarker evaluation.
    Cancer Chemother Pharmacol. 2007;.
    PubMed     Related articles    Abstract available
    
    
    October 2007
15. ADDEO R , Faiola V, Guarrasi R, Montella L, et al
    Liposomal pegylated doxorubicin plus vinorelbine combination as first-line chemotherapy for metastatic breast cancer in elderly women >/=65 years of age.
    Cancer Chemother Pharmacol. 2007;.
    PubMed     Related articles    Abstract available
    
    
    September 2007
16. BAILEY HH , Attia S, Love RR, Fass T, et al
    Phase II trial of daily oral perillyl alcohol (NSC 641066) in treatment-refractory metastatic breast cancer.
    Cancer Chemother Pharmacol. 2007;.
    PubMed     Related articles    Abstract available
    
    
    
17. OSAKO T , Ito Y, Takahashi S, Tokudome N, et al
    Efficacy and safety of trastuzumab plus capecitabine in heavily pretreated patients with HER2-positive metastatic breast cancer.
    Cancer Chemother Pharmacol. 2007;.
    PubMed     Related articles    Abstract available
    
    
    August 2007
18. GHOSN M , Kattan J, Farhat F, Younes F, et al
    Sequential vinorelbine-capecitabine followed by docetaxel in advanced breast cancer: long-term results of a pilot phase II trial.
    Cancer Chemother Pharmacol. 2007;.
    PubMed     Related articles    Abstract available
    
    
    
19. BONNETERRE J , Campone M, Koralewski P, Blasinska-Morawiec M, et al
    Vinorelbine/docetaxel combination treatment of metastatic breast cancer: a phase I study.
    Cancer Chemother Pharmacol. 2007;60:365-73.
    PubMed     Related articles    Abstract available
    
    
    
20. YUVARAJ S , Premkumar VG, Vijayasarathy K, Gangadaran SG, et al
    Augmented antioxidant status in Tamoxifen treated postmenopausal women with breast cancer on co-administration with Coenzyme Q(10), Niacin and Riboflavin.
    Cancer Chemother Pharmacol. 2007;.
    PubMed     Related articles    Abstract available
    
    
    
21. RIBATTI D
    The contribution of Gianni Bonadonna to the history of chemotherapy.
    Cancer Chemother Pharmacol. 2007;60:309-12.
    PubMed     Related articles    Abstract available
    
    
    
22. FANDY TE , Ross DD, Gore SD, Srivastava RK, et al
    Flavopiridol synergizes TRAIL cytotoxicity by downregulation of FLIPL.
    Cancer Chemother Pharmacol. 2007;60:313-9.
    PubMed     Related articles    Abstract available
    
    
    July 2007
23. MASUDA N , Taguchi T, Nakayama T, Shiba E, et al
    Capecitabine and paclitaxel combination chemotherapy for inoperable or recurrent breast cancer: a phase I dose-finding study by the Kinki Breast Cancer Study Group.
    Cancer Chemother Pharmacol. 2007;.
    PubMed     Related articles    Abstract available
    
    
    
24. ROCCA A , Viale G, Gelber RD, Bottiglieri L, et al
    Pathologic complete remission rate after cisplatin-based primary chemotherapy in breast cancer: correlation with p63 expression.
    Cancer Chemother Pharmacol. 2007;.
    PubMed     Related articles    Abstract available
    
    
    
25. HONG RL , Lin CH, Chao TY, Kao WY, et al
    A phase-I study evaluating the combination of pegylated liposomal doxorubicin and paclitaxel as salvage chemotherapy in metastatic breast cancer previously treated with anthracycline.
    Cancer Chemother Pharmacol. 2007;.
    PubMed     Related articles    Abstract available
    
    
    
26. CIOMEI M , Croci V, Stellari F, Amboldi N, et al
    Antitumor activity of edotecarin in breast carcinoma models.
    Cancer Chemother Pharmacol. 2007;60:229-35.
    PubMed     Related articles    Abstract available
    
    
    May 2007
27. YAMAMOTO D , Iwase S, Kitamura K, Odagiri H, et al
    A phase II study of trastuzumab and capecitabine for patients with HER2-overexpressing metastatic breast cancer: Japan Breast Cancer Research Network (JBCRN) 00 Trial.
    Cancer Chemother Pharmacol. 2007;.
    PubMed     Related articles    Abstract available
    
    
    
28. LEE J , Im YH, Lee SH, Cho EY, et al
    Evaluation of ER and Ki-67 proliferation index as prognostic factors for survival following neoadjuvant chemotherapy with doxorubicin/docetaxel for locally advanced breast cancer.
    Cancer Chemother Pharmacol. 2007;.
    PubMed     Related articles    Abstract available
    
    
    April 2007
29. O'CONNOR T , Rustum Y, Levine E, Creaven P, et al
    A phase I study of capecitabine and a modulatory dose of irinotecan in metastatic breast cancer.
    Cancer Chemother Pharmacol. 2007;.
    PubMed     Related articles    Abstract available
    
    

Thank you for your interest in scientific medicine.

Amedeo is a Bernd Sebastian Kamps website.    Design: